AdaptHealth Corp. (NASDAQ:AHCO) traded at $29.98 at last check on Friday, Nov 20, making an upward move of 1.77% on its previous day’s price.
Looking at the stock we see that its previous close was $29.46 and the beta (5Y monthly) reads 0 with the day’s price range being $28.92 – 30.00. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, AHCO has a high of $31.8 and a low of $7.82. The company’s stock has gained about 13.35% over that past 30 days.
AdaptHealth has a market cap of $2.64 Billion and is expected to release its quarterly earnings report on November 04, 2020. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the AHCO stock to lose ahead of the earnings release. Estimates by analysts give the company expected earnings per share (EPS) of $0.16, with the EPS growth for the year raised at $0.2 for 2020 and $0.88 for next year. These figures represent -1.3% and at 3.4% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $318.22 Million, with a low of $311.4 Million and a high of $331.8 Million. The median projection represents growth adding up to 112.8% compared to sales earnings for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecasts for 2020 are expected to hit $1.03 Billion, or +93.7% up from figures reported last year.
There have been 1 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the AHCO stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Based on estimates by 7 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, none have rated the AdaptHealth Corp. (AHCO) stock as a Hold, while 6 rate it as a Buy. 1 analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the AHCO stock currently stands at 0, and the current price level is 4.17% off its SMA20 and 15.37% from its 50-day simple moving average. The RSI (14) is pointing at 63.87 while the volatility over the past week is 5.55% and jumps to 6.88% over the past one month. The beta value is 0, while the average true range (ATR) is currently pointing at 1.8. The average price target for the stock over the next 12 months is $34.93, with the estimates having a low of $32.5 and a high of $36. These price ends are 8.41% and +20.08% off the current price level respectively, although investors could be excited at the prospect of a +20.08% if the AHCO share price touches on the median price of $36.
Let’s briefly compare AdaptHealth (AHCO) stock to its peers. We find that today’s price change of +1.77% and +269.67% over the past 12 months for AHCO betters that of Abbott Laboratories (ABT), which has seen its stock price fall -0.1% in the latest trading session and is +32.52% over the last one year. Another of its peers Medtronic Inc (MDT) has dropped -0.76% today, but is -0.3% down over the past year, while Stryker Corp (SYK) is also up 1.77% yet its price remains in the green at 269.67% over the same period. Abbott has a P/E ratio of 58.98 compared to AdaptHealth’s 0 and Medtronic’s 33.99. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to AdaptHealth Corp. (NASDAQ:AHCO), we note that the average 3-month trading volume was 419.01 Million, while that of the preceding 10-day period stands at 424.68 Million. Current shares outstanding are 64.03 Million.
According to data from Thomson Reuters, insiders hold 27.75% of the company’s shares while institutions hold 58.4%. The data shows that short shares as of October 29, 2020, stood at 1.36 Million at a short ratio of 4.05. This represents a 1.54% Short interest in Shares outstanding on October 29, 2020. Shares short rose in October from the previous month at 1.06 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +173.04% up in year-to-date price movement.